National Trends in Outpatient Quality Indicators

描述：尽管人们越来越关注医疗保健质量 在美国，提高全国的门诊医疗质量 尚未对服务进行评估。尤其缺乏的是严格的评估 关于种族和族裔少数群体门诊服务质量的趋势。 该应用程序将使用1992-2001年的数据来解决此问题 国家非卧床医疗服务调查(NAMCS)和国家医院 动态医疗护理调查(NHAMCS)。它的目的是：1)构造一个集合 门诊质量指标，2)评估国家医疗服务质量 使用所选指标的水平，3)评估这些指标的时间趋势 指标，以及4)确定患者、医生和组织预测因素 (C)提高保健质量，特别注重少数族裔。一套 27个拟议的质量指标将提供对 质量和将包括：1)推荐的药物(例如，心房的华法林 纤颤)，2)抗生素的使用(例如，病毒呼吸道中的抗生素 感染)，3)医生咨询/疾病管理(例如，饮食 糖尿病咨询)，4)诊断性测试(例如，筛查尿检 测试)，以及5)用药错误(例如，危险的药物-药物相互作用)。

DESCRIPTION: Despite the increasing attention on health care quality improvement in the U.S., the national quality of outpatient health care services has not been assessed. Particularly lacking are rigorous evaluations of trends in the quality of outpatient care for racial and ethnic minorities. This application will address this issue using data from the 1992-2001 National Ambulatory Medical Care Surveys (NAMCS) and National Hospital Ambulatory Medical Care Surveys (NHAMCS). Its aims are to: 1) construct a set of outpatient quality indicators, 2) assess quality of care at the national level using the selected indicators, 3) evaluate time trends in these indicators, and 4) determine patient, physician and organizational predictors of quality of care, with a particular focus on racial/ethnic minorities. A set of 27 proposed quality indicators will provide a quantitative assessment of quality and will cover: 1) recommended medications (e.g., warfarin in atrial fibrillation), 2) antibiotic use (e.g., antibiotics in viral respiratory infections), 3) physician counseling/disease management (e.g., dietary counseling in diabetes), 4) diagnostic testing (e.g., screening urinalysis tests), and 5) medication errors (e.g., risky drug-drug interactions).